Adherence and persistence of mirabegron and anticholinergic therapies in patients with overactive bladder: a real-world claims data analysis
Author:
Affiliation:
1. Division of Urology; Department of Surgery; Rowan University School of Osteopathic Medicine; Stratford NJ USA
2. Allergan Inc; Irvine CA USA
3. Xcenda; Palm Harbor FL USA
4. St Peter's Health Partners; Albany NY USA
Funder
Allergan
Publisher
Hindawi Limited
Subject
General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ijcp.12824/fullpdf
Reference17 articles.
1. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline;Gormley;J Urol,2012
2. Mirabegron - a beta-3 adrenergic agonist for overactive baldder syndrome: a review;Parasuraman;Int J Res Pharm Sci,2013
3. National community prevalence of overactive bladder in the United States stratified by sex and age;Coyne;Urology,2011
4. The influence of an overactive bladder on falling: a study of females aged 40 and older in the community;Moon;Int Neurourol J,2011
5. Patient-reported reasons for discontinuing overactive bladder medication;Benner;BJU Int,2010
Cited by 49 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Improvement of medication adherence for desmopressin by adjusting the prescription dosage in male patients with overactive bladder: A claims database analysis;Neurourology and Urodynamics;2024-07-09
2. Comparative analysis of real‐world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims study;Neurourology and Urodynamics;2024-05-08
3. Comparison of Use of Propiverine at 45 mg and Combined Treatment of Propiverine 30 mg and Mirabegron in Patients with Overactive Bladder Who did not Benefit from Propiverine 30 mg Treatment;Gazi Medical Journal;2024-04-01
4. Does the setting for intradetrusor onabotulinumtoxinA injection for management of overactive bladder matter?;Indian Journal of Urology;2024-04
5. Predictors of non-persistence in women with overactive bladder syndrome;Scientific Reports;2024-03-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3